Describes a multimodal explainable AI framework to predict Parkinson's disease from heterogeneous data sources, emphasizing interpretability rather than biological mechanisms.

Improved interpretable prediction could help identify candidate biomarkers and stratify patients for trials, but with no abstract and little mechanistic or therapeutic content the paper has limited direct value for drug discovery.